eHealth mHealth HealthTech innovations - Marketing Santé innovant
47.3K views | +6 today
Follow
 
Scooped by Dominique Godefroy
onto eHealth mHealth HealthTech innovations - Marketing Santé innovant
Scoop.it!

Bercy passe au crible les applications mobiles de santé connectée

Bercy passe au crible les applications mobiles de santé connectée | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
La direction générale de la concurrence, de la consommation et de la répression des fraudes (DGCCRF) s'est penchée sur 25 applications de e-santé dans le cadre d'une enquête publiée début janvier, où elle émet des recommandations sur la collecte des données et prévient qu'elle continuera à surveiller le secteur.

Les 25 applications sont téléchargeables "dans les magasins virtuels des systèmes d’exploitation pour smartphones ou tablettes", précise la DGCCRF.

Les services de Bercy ont contrôlé deux types d'applis:

Les premières relèvent davantage de la sphère du bien-être et proposent un accompagnement et des conseils de remise en forme, d’exercice, de régime alimentaire par le biais d’un suivi renseigné directement par l’utilisateur ou alors mesuré par les capteurs du smartphone ou via des objets connectés (balance connectée, bracelet d’activités, podomètre…).

Les autres applications sondées vont plus loin que la simple quantification du bien-être et prétendent, elles, apporter une aide au diagnostic médical.

Ces applications liées à des pathologies proposent un suivi, un diagnostic ainsi que des informations sur les maladies ou médicaments destinées à rendre la vie du patient plus facile, comme les applications d’aide au suivi du diabète par exemple.
more...
No comment yet.
eHealth mHealth HealthTech innovations - Marketing Santé innovant
Digital, Apps, IoT, devices, AI / DL (...) innovations for Health and Healthcare
Your new post is loading...
Your new post is loading...
Scooped by Dominique Godefroy
Scoop.it!

AI & RPA in Public Healthcare: Transforming Patient Outcomes

AI & RPA in Public Healthcare: Transforming Patient Outcomes | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
We are living much longer than previous generations, while the funding and resourcing for public sector healthcare struggles to meet these expanding demands. The UK population is a prime example of a country living longer, with certain areas such as West Somerset already having 1 in 3 over 65, and by 2046 25% of UK the population will be within this bracket. Exacerbating this issue, it is predicted that staff shortages could reach 250,000 by 2030 without urgent action. As the country, and also the globe, is affected by such demographic issues, it makes long term planning and focus towards the use of technology to solve issues paramount to the future of a functioning healthcare system.

On the 7th of January, the UK Government published the long-term plan for the NHS. An ambitious plan for improvements within the NHS, which has been described as a “blueprint to make the NHS fit for the future”, with the aim of “saving almost half a million lives” . As part of these bold plans, the Government set out key digital transformation aims and states the importance of technology to underpin the future of the NHS. The UK Government has seen the importance of driving digital technology within the NHS, joining in partnership with 13 other global nations to revolutionise the health service delivered globally.

The plan outlines a future in which technology such as Artificial Intelligence (AI) is front and centre. With the aim of eliminating waste and boosting cutting edge AI, the Government set out target aims of saving up to £700 million pounds across the NHS in office based work and “open a ‘front door’ to the health service”.

A patient outcome focus requires public healthcare providers, like the NHS, to rethink their resourcing structures in order to operate more efficiently. Especially, to digitise healthcare provisions and to match the expectations of the Government on delivery of patient outcomes. So, how could RPA & AI automation be used to address resourcing structures and help public sector providers deliver?
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Novartis and Uni of Oxford to join forces and use AI for diseases and drug development

Novartis and Uni of Oxford to join forces and use AI for diseases and drug development | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Novartis and the University of Oxford’s Big Data Institute have announced that they are to establish a five-year research alliance using artificial intelligence to understand complex diseases and improve drug development.

The alliance plans to analyse huge data sets using artificial intelligence and machine learning to spot disease insights that have been undetectable to scientists thus far, expecting to transform how ultra large and multiple datasets are analysed, combined and interpreted to identify early predictors of patient responses to treatments for inflammatory diseases, such as multiple sclerosis (MS) and psoriasis.

The alliance will draw on data from around 5 million patients from the UK and international partner organisations, together with anonymised data captured from relevant Novartis clinical trials.

Using the BDI’s latest statistical machine learning technology and experience in data analysis, combined with Novartis’ wealth of clinical expertise and clinical trial data, the alliance expects to predict how patients will respond to existing and new medicines.

“Our collaboration with Novartis will enable both organisations to transform the scale and efficiency of clinical research at an unprecedented rate though the sharing of data, technology, and advanced analytics expertise” said Professor Gil McVean, director of the Big Data Institute.

“The BDI enables people and projects to span traditional boundaries and scientific disciplines, and leverage technological innovation for the benefit of patients.”
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Health chatbots show potential, but challenges remain

Health chatbots show potential, but challenges remain | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
The consumer platform company looked at five healthcare chatbots: Ada, HealthTap, Mediktor, Your.MD and Symptomate. Chatbot apps were especially challenged by complex conditions, with all experiencing sharp declines in scores when asked to diagnose complex symptoms, such as food poisoning — often leading to alarming results.

Consumers also had concerns about personal health information and HIPAA compliance, especially with less familiar brands. “Oversights in general usability also contributed to lack of trust,” according to the report. “Some of the key complaints mentioned spelling errors, and suggested links to providers or content that seemed untrustworthy or fake.”

There were also lots of basic usability issues. For example, loading issues with HealthTap forced many users to exit the app and start the diagnosis process all over again.

Nearly all of the study participants had some prior experience using chatbots, and nearly half used them to research medical symptoms. Still, the report cites data showing 50% of people who download health-related mobile apps eventually abandon them because of usability problems.

Overall, Ada fared the best at 84.3, followed by Mediktor (80.1), Your.MD (75.8), Symptomate (72.6) and HealthTap (40.5).

“Customers have high expectations when it comes to their digital experiences,” Janelle Estes, chief insights officer at UserTesting, said in a statement.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Proteus launches its first digital cancer chemotherapy pill

Proteus launches its first digital cancer chemotherapy pill | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Smart-pill maker Proteus Digital Health has launched an oral chemotherapy equipped with its ingestible sensor, which aims to help oncologists track treatment effectiveness and adherence in their cancer patients.

The digital pill is first being offered as part of a collaboration between the former Fierce 15 winner, the University of Minnesota health system and Fairview Health Services, a nonprofit network of Minnesota clinics.

They will be prescribing digital capecitabine to treat patients with stages 3 and 4 colorectal cancer, with the opportunity to better intervene if patients are not taking their medication correctly or miss a dose. The pill’s embedded sensor activates in stomach acid and sends an electronic signal before being dissolved.

“Proteus’ digital medicine technology provides a more direct connection to the patient,” said Edward Greeno, who directs the University of Minnesota Health oncology service line.

“It creates a way for us to achieve a lot of things that happen when a patient is in the clinic for infusions without them coming in person,” Greeno said in a statement. “Also, we can gain insights about the patient that we can’t learn from an office visit, like how the patient is doing with their treatment regimen while at home, on a daily basis.”

According to Proteus, the digital medicine program can help optimize oral regimens by recording the time, dose and type of chemotherapy taken, and merge with data on rest, activity and resting heart rate. The information can also be shared with pharmacists or caretakers through Proteus’ secure mobile platform.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Verily raises $1 billion to expand its healthcare beyond research

Verily raises $1 billion to expand its healthcare beyond research | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Verily, the life sciences arm of Google-parent company Alphabet, raised $1 billion from investors to support its healthcare play beyond research. Verily plans to use the funds to bolster growth in key areas like investments in new strategic partnerships and potential acquisitions.

The influx of cash should help Verily's ongoing pivot toward commercializing health products. Most of Verily's previous work in healthcare has focused on research: Verily's conducting a study in conjunction with biopharmaceutical firm Gilead Sciences that aims to identify the genomic cause of inflammatory disease, for example.

And it's also partnering with Duke University and Stanford Medicine to research risk factors that lead to disease onset. But Verily's recent initiatives suggest the firm is focusing more on developing and marketing products beneficial to healthcare stakeholders across the ecosystem to drive revenue.

For example, Verily spun out a joint venture with sleep-tracking device company ResMed in July 2018 to help providers treat sleep apnea, an underdiagnosed disorder linked with $150 billion in annual US economic costs. And the firm formed a pact with Walgreens in December 2018 that allows Verily to market health products in Walgreens locations, including devices and software to help manage diabetes and improve medication adherence.

more...
No comment yet.
Rescooped by Dominique Godefroy from Pharma Hub
Scoop.it!

This Algorithm Finds Ways to Make Life-Saving Drugs While Avoiding Patents

This Algorithm Finds Ways to Make Life-Saving Drugs While Avoiding Patents | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

The researchers expect the algorithm will be used to both create stronger patents and navigate around existing pharmaceutical patents.

 

A team of Polish and South Korean researchers made a computer program that develops new production methods for existing life-saving drugs without infringing on the drug patents of pharmaceutical companies.

 

The researchers expect that their new method may be used to create even more robust pharmaceutical patents in the future. On the flipside, though, they acknowledge that their work could be used to “[navigate] around patented methodologies” as well.


Via Philippe Marchal
more...
Rescooped by Dominique Godefroy from GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK
Scoop.it!

Digital medicine startup Proteus Digital Health pushes into oncology  #esante #hcsmeufr

Digital medicine startup Proteus Digital Health pushes into oncology  #esante #hcsmeufr | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Proteus' new oral oncology drug is a digital version of capecitabine, a common chemotherapy medication often used to treat breast and gastrointestinal cancers.

 

Silicon Valley startup Proteus Digital Health has partnered with Fairveiw Health Services and the University of Minnesota Health system to provide its digital medicine technology to cancer patients to support chemotherapy treatments.

 

Proteus creates so-called smart pills, ingestible digital sensors that can track medication adherence and activity levels. Based in Redwood City, California, the company has raised nearly $500 million from investors like pharmaceutical heavyweights Novartis and Otsuka.


Via Lionel Reichardt / le Pharmageek
more...
Scooped by Dominique Godefroy
Scoop.it!

Une appli pour garder sa voix malgré le cancer du larynx

Une appli pour garder sa voix malgré le cancer du larynx | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Les personnes atteintes d'un cancer du larynx doivent souvent en subir l'ablation. Au péril de leurs cordes vocales, justement situées dans le larynx... Les patients perdent ainsi l'usage de leur voix. Un procédé high-tech développé par deux universités tchèques permet toutefois de la préserver. Plus précisément, de la simuler, grâce à des enregistrements vocaux réalisés avant l'opération, qui permettent de modéliser finement le timbre sonore ! Grâce à une tablette ou un smartphone et à un outil de synthèse vocale, il est possible de dialoguer de nouveau avec ses proches. Et ce, avec sa "vraie" voix !


Synthèse vocale plutôt que prothèse vocale

En 2018, Vlastimil Gular s'attendait à une intervention mineure sur ses cordes vocales, mais les médecins ont diagnostiqué un cancer et prévu d'enlever son larynx. Il était censé perdre l'usage de la voix. Pourtant, on l'entend toujours aujourd'hui. Ce père de quatre enfants âgé de 51 ans continue à bavarder en faisant entendre sa propre voix plutôt que le timbre métallique d'un robot, grâce à une application sur son téléphone portable : il lui suffit de saisir au clavier ce qu'il souhaite dire.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Amazon Web Services: AI, data analytics and cloud are converging to drive down costs and boost care quality

Amazon Web Services: AI, data analytics and cloud are converging to drive down costs and boost care quality | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Healthcare companies are using artificial intelligence and machine learning, and then the cloud to better ingest, manage and leverage a variety of data – whether it is structured data, unstructured data or streams, to break down silos and enable data liquidity in support of collaborative research and care coordination.

"The cloud enables healthcare providers to scale up during peak demand periods, like flu season, and scale back down again when demand has ebbed," said Shez Partovi, director of worldwide healthcare and life sciences, business and market development at Amazon Web Services. "They can then process the data, apply deep learning, and visualize the data in order to make insightful decisions throughout a patient's care journey – or even throughout the research pipeline."

For instance, Orion Health hosts data for 50 million users on the AWS Cloud, enabling its customers to access patient information ranging from clinical information and genomics to claims and reimbursement data, Partovi added. In turn, providers can identify personalized treatment and prevention strategies and optimize clinical decision making.

"Additionally, AI and machine learning are providing the tools to process and analyze the increasing amount of data generated by doctors, hospitals, researchers and organizations, including structured data like EHR forms as well as unstructured data, such as emails, text documents and even voice notes," said Patrick Combes, technology leader, healthcare and life sciences, at AWS.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

How Chatbots and AI are Influencing the Healthcare Industry

How Chatbots and AI are Influencing the Healthcare Industry | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
You click open the homepage of a product website and immediately a small chat window pops up from the bottom right corner. It is displaying the message “Hi, I am Janet. How may I assist you today?” A few years back, you would have been startled (and pleased) but now you just start typing in even though you know you are describing your problem to an artificial conversational entity – the chatbot.

Thanks to that marriage made in heaven between natural language processing and machine learning, the chatbots are getting to be more responsive, smarter and therefore more human-like in their conversational abilities. Moreover, being software which can crunch up loads of data in seconds, the chatbots are also superhuman – alert, data-driven, dedicated, untiring, reliable and most importantly, available 24/7. The bots are also free from the human flaws of laziness, prejudice, impulsiveness and most importantly (for the healthcare domain), carelessness.


Chatbots and Healthcare

Although chatbots in general, have taken the business world by storm, it is soon evident that where healthcare domain is concerned, chatbots are veritably bringing about a major paradigm shift.
And why?

The modern humans, while healthy, may favour solitude, immersing in social media and other technology based distractions but when down and ill, still crave for a sympathetic and reassuring voice and an attentive ear, not to say, someone to remember the suffering and remind and urge to take steps towards cure.

Except that, by now, as children of the on-demand, instant gratification culture, waiting is unacceptable. Hence, the chatbots - the ultimate in support and assistance for a not so narrow range of tasks traditionally performed by tier-1 patient engagement operatives. Comprised of just a few lines of code, the chatbot added as a contact in a person’s favorite social messaging application immediately adds that person into bot provider’s information network.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

FDA Clears RAPID AI Software for Selecting Stroke Victims for Clot Removal

FDA Clears RAPID AI Software for Selecting Stroke Victims for Clot Removal | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

The U.S. Food and Drug Administration (FDA) has cleared iSchemaView’s RAPID neuroimaging platform for use in selecting acute stroke patients who are likely to benefit from endovascular thrombectomy, according to iSchemaView’s announcement today.

RAPID, developed by stroke experts, uses artificial intelligence (AI) framework that, according to iSchemaView, combines expert feature extraction and proprietary algorithms to identify stroke patients that should get their clot removed. The software aids clinicians in diagnosing and treating stroke victims more quickly.

Because of the clearance, RAPID computed tomography (CT)-Perfusion and RAPID magnetic resonance (MR)-Perfusion can be used by physicians to help select acute stroke patients with known obstruction of the internal carotid artery or proximal middle cerebral artery for a clot removal procedure.

According to the company, RAPID is the only imaging platform approved for selecting stroke patients for clot removal.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Medtech therapeutic areas to track in 2019

Medtech therapeutic areas to track in 2019 | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Medtech trends today don't discriminate across health conditions. Patients have their pick of wristwear to measure stroke risk or blood pressure. One app tracks asthma and chronic obstructive pulmonary disease, another helps manage substance addictions, and a third connects patients and surgeons during post-operation recovery

While it seems like these consumer-oriented tech trends touch every corner of the industry, some therapeutic areas stand out as particularly poised for growth.

Chronic diseases present the biggest opportunities, said Glenn Snyder, medical technology sector leader at Deloitte, in an interview. He described a patient's "care journey" as segmented into stages of "well care," diagnosis, treatment decision, acute care itself, and chronic or post-acute care.

Whereas traditional therapeutic device companies typically have a stronghold on the acute treatment space, Snyder said much of the opportunity seen today by emerging medtech players seizes on either end of that spectrum: prevention and patient monitoring.

"The back end is where so much money is spent today in terms of chronic care, and it becomes a better return on investment," Snyder said. "There are still unmet needs in those areas for sure, so I think we'll continue to see more innovation in those spaces."

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Stanley Black & Decker Getting Into Healthcare: CES 2019

Stanley Black & Decker Getting Into Healthcare: CES 2019 | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
The names Black & Decker and Stanley conjure thoughts of sawing wood planks, drilling holes, as well as mixing up dough for your secret bread recipe. They certainly don’t make one think of medical devices. But the joined company, called Stanley Black & Decker, now has a division called STANLEY Healthcare that already has a number of products designed specifically for use in clinics and by patients at home.

At CES 2019, the company was presenting its new Pria by BLACK+DECKER Home Care Companion, a smart device that can dispense medications at the right time and a digital voice assistant that can help with managing one’s health, scheduling tasks, and keeping in touch with caregivers should something happen.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

The VA Wants to Use DeepMind's AI to Prevent Kidney Disease

The VA Wants to Use DeepMind's AI to Prevent Kidney Disease | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
The human body is frail and people end up in intensive care units for all kinds of reasons. Whatever brings them there, more than half of adults admitted to an ICU end up sharing the same potentially life-threatening condition: kidney damage known as acute kidney injury.

The Veterans Administration thinks artificial intelligence could reduce the toll. In a project that drew on roughly 700,000 medical records from US veterans, the agency worked with Google parent Alphabet’s DeepMind unit to create software that attempts to predict which patients are likely to develop AKI. The VA hopes to test whether those predictions can help doctors prevent people from developing the condition. AKI manifests as a sudden failure of the kidneys to properly remove waste from the body, and often occurs as a complication of surgery, infection, or other stresses of hospitalization.

The project is an example of the worldwide push to save lives using the AI techniques that power internet companies’ virtual assistants and facial recognition. The spread of digital health records offers a torrent of data about patients, including subtle patterns that algorithms can interpret in ways doctors cannot. In the US and other rich countries, AI is seen as a way to improve care and cut costs. In places like India and China with chronic shortages of medical specialists, the technology could improve access to care.

DeepMind’s collaboration with the VA fits into a broader push into health care by Alphabet. The company hopes to use AI to diversify beyond advertising, which supplies nearly 90 percent of its revenue. Other Alphabet projects are training algorithms to detect eye disease and cancer. Google recently hired veteran health system executive David Feinberg to take charge of its health projects.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Détecter des maladies sur le visage grâce à l'IA et la reconnaissance faciale

Détecter des maladies sur le visage grâce à l'IA et la reconnaissance faciale | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Au-delà de déverrouiller son smartphone ou son ordinateur, la reconnaissance faciale pourrait s’avérer bien plus utile qu’il n’y parait. Combinée à une intelligence artificielle, celle-ci permettrait d’aider à détecter des maladies sur le visage de patients.

Présentes dans notre quotidien, les nouvelles technologies peuvent paraître sous-exploitées. Pourtant, ces innovations sont pour la plupart développées en laboratoire scientifique ou, en tout cas, étudiées par des chercheurs compétents. Certains tentent même de les combiner afin d’exploiter au maximum leurs bienfaits.

C’est ainsi que la société FDNA s’est penchée sur l’association d’une intelligence artificielle à la reconnaissance faciale. Dans son étude, dont les résultats ont été publiés dans la revue médicale Nature Medecine, la société indique avoir mis au point un outil capable de dépister des maladies génétiques de manière non invasive. Cet outil, le DeepGestalt, combine la reconnaissance faciale à un algorithme d’apprentissage automatique.

Pour mettre au point son outil, la société s’est penchée sur une base de données de plus de 17.000 clichés de patients. Un exercice qui a permis d’entraîner l’intelligence artificielle à détecter plus de 200 syndromes. Ainsi, elle est capable de repérer des signes de maladies génétiques sur le visage des patients.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Industry Voices—How data analytics can help physician practices transition to value-based care models

Industry Voices—How data analytics can help physician practices transition to value-based care models | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

In order to grapple with spending increases, the U.S. healthcare industry is transforming the way physicians are compensated to provide care to patients from the current fee-for-service (FFS) model to one in which medical providers are paid a flat fee for servicing a defined group of patients.

This pivot in reimbursement is often discussed as far off. A survey by Numerof & Associates, a St. Louis, Missouri-based healthcare strategy consultancy, finds that most health organizations have been slow to make the shift: 54% receive less than 10% of their revenue from risk-based agreements.

However, as consumers become more sophisticated, and payers and health systems become more emboldened to wring out costs, we expect to see the shift in reimbursement models take off in the coming years. Provider groups that embrace this shift now have an opportunity to gain meaningful first-mover advantages.

Policy changes will further enhance the transition. Annual FFS pricing increases are set by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), and physicians treating Medicare patients will receive FFS raises of 0.5% this year and next. Then, from 2020 through 2024, there will be no automatic payment increases.

That’s not a recipe for growing revenues. But instead of fearing the transition to a value-based compensation model, physician groups that have the foresight and inclination to harness analytic tools, patient data, and standardized processes will have a leg up on other practices, positioning them to win new contracts with payers and systems, and capture more patient volumes.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Les Etats-Unis, un "faux eldorado" pour les start-up françaises de la santé connectée (Bpifrance)

Les Etats-Unis, un "faux eldorado" pour les start-up françaises de la santé connectée (Bpifrance) | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Alors que le Consumer Electronics Show (CES), qui s'est tenu du 8 au 11 janvier à Las Vegas (Nevada), a encore fait le plein cette année de start-up françaises de la santé connectée, la directrice du fonds Patient autonome de Bpifrance, Chahra Louafi, a pointé dans un entretien à TICpharma les particularités de ce marché, estimant que les Etats-Unis sont un "faux eldorado" pour les jeunes entreprises innovantes du secteur.

TICpharma.com: Quel bilan tirez-vous après un an à la direction du fonds Patient autonome de Bpifrance (lire dépêche du 16 avril 2018)?

Chahra Louafi: Le constat qui a motivé la création du fonds est toujours valable: les coûts de santé explosent, le régulateur exerce une pression sur les prix et essaye de circonscrire au maximum les marchés des produits de santé, le temps médical est de plus en plus rare et le patient de plus en plus autonome grâce au digital. Le marché de la santé numérique est quant à lui extrêmement morcelé, notamment en termes de modèles économiques. Mais ce qui reste encore compliqué à évaluer lorsqu'on doit faire des choix d'investissement est le temps que prendra l'usage d'un nouvel outil digital à s'installer dans les pratiques. C'est la seule inconnue qu'on peut avoir, et qui nécessite que tout le reste soit extrêmement bien encadré.

C'est-à-dire?
C.L.: Il faut que la société qui développe un outil ait une équipe très expérimentée, à la fois sur les volets technique et médical, et qu'elle ait bien analysé ses besoins de financement jusqu'à la commercialisation de son produit ou service. Inclure très en amont les futurs clients du produit, comme les professionnels ou les établissements de santé, est aussi un excellent signe dans ces modèles où le client va tirer l'usage. On voit de plus en plus de profils de 'médecins geeks' et entrepreneurs. C'est un bon signal car cela démontre que le besoin auquel répond la technologie n'est pas adressé dans la pratique quotidienne.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Au CES 2019, robots, mini-frigo, outils connectés de radioprotection: des innovations pour les ingénieurs hospitaliers

Au CES 2019, robots, mini-frigo, outils connectés de radioprotection: des innovations pour les ingénieurs hospitaliers | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Alors que le Consumer Electronics Show (CES) de Las Vegas a fermé ses portes le 11 janvier, l'heure du bilan pour les start-up françaises a sonné, et pour ce faire TecHopital a sélectionné une dizaine d'innovations susceptibles d'intéresser les ingénieurs hospitaliers.

Cette année, 335 sociétés françaises ont fait le déplacement jusqu'à Las Vegas pour cette grand-messe internationale de l'innovation technologique. D'année en année, les spécialistes constatent que la santé émerge comme l'un des secteurs les plus dynamiques parmi les 25 catégories de produits couvertes par le salon.

La santé "digitale" figure parmi les "secteurs clés" du CES, avec la "ville intelligente" (smart city) et le transport. Et l'e-santé est le troisième secteur le plus primé après les objets connectés et la mobilité.

TecHopital a sélectionné une petite dizaine de start-up françaises pour leurs innovations en e-santé et en objets connectés. Il s'agit de Lifeina, Meersens, Numii, les robots R3D3 de Green Creative et le robot Charlie de New Health Community, mais aussi Icohup, Koovea, Blue Whale Company ou Flovea.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Apple Watch, Johnson & Johnson team up on study to reduce stroke risk

Apple Watch, Johnson & Johnson team up on study to reduce stroke risk | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Apple and Johnson & Johnson are teaming up on a study to determine whether the latest Apple Watch, in conjunction with an app from the pharmaceutical company, can accelerate the diagnosis of a leading cause of stroke.

Atrial fibrillation, or AFib, is an irregular and often rapid heart rate that causes about 130,000 deaths and 750,000 hospitalizations each year in the U.S., Johnson & Johnson said. Up to 30 percent of cases go undiagnosed until life-threatening complications occur. Worldwide, about 33 million people have the condition.

The controlled, randomized multi-year Johnson & Johnson study will start later this year and be limited to U.S. adults ages 65 years and older who wear the Apple Watch Series 4. Specific details on how to participate will be released later.

The Apple Watch Series 4, which costs $399 or more, has an irregular heart rhythm notification feature, as well as an FDA-cleared ECG app, both of which are designed to detect AFib.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

All of Us enrollees can now share health data from their Fitbit accounts with researchers

All of Us enrollees can now share health data from their Fitbit accounts with researchers | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
The National Institutes of Health made it clear from the start that Fitbit’s wearables would play a key role in the agency’s ambitious All of Us Research Program.

Now, eight months and more than 100,000 enrollees down the road, the agency and the device maker have announced that anyone who owns a Fitbit and has already enrolled in the program may consent to release the activity, heart rate, sleep and other health data stored in their Fitbit account with NIH’s researchers.

“Collecting real-world, real-time data through digital technologies will become a fundamental part of the program,” Eric Dishman, director of the All of Us Research Program, said in a statement. “This information in combination with many other data types will give us an unprecedented ability to better understand the impact of lifestyle and environment on health outcomes and, ultimately, develop better strategies for keeping people healthy in a very precise, individualized way.”

Interested participants may begin syncing their data by visiting the “Sync Apps & Devices” page of the All of Us website. Users may use their Fitbit devices to directly sync their health data with the program, or manually input information such as weight or water intake into their Fitbit account and upload from there, according to a press release.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

ADEL se dévoile à Las Vegas

ADEL se dévoile à Las Vegas | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Avec le développement de la chirurgie ambulatoire, la possibilité de contacter plus facilement les équipes médicales et l’accès facilité à une information qui peut être de très bonne qualité (malgré tout), on pourrait être tenté de croire que subir une intervention chirurgicale non urgente est (presque) facile. Pourtant, l’anxiété des patients demeure. Liée d’abord à l’intervention en elle-même, elle est accrue par un ensemble de détails pratiques (démarches administratives, orientation dans la clinique ou l'hôpital, interrogations sur le suivi etc). Pour alléger ces inquiétudes, de plus en plus de centres de santé réfléchissent à la mise en place d’outils numériques.


Un partenariat fructueux

C’est ainsi qu’à l’occasion du Consumer Electronics Show (CES) qui s’est tenu à Las Vegas cette semaine a été présenté l’assistant numérique conçu par le groupe de cliniques privées ELSAN (deuxième groupe de cliniques en France). ADEL est une application numérique dont la spécificité est d’assurer un accompagnement du patient à chaque étape de son parcours : avant l’intervention, au moment de son séjour à la clinique et après sa sortie. Le projet ADEL avait déjà été présenté lors du salon VivaTech à Paris au printemps dernier. Ce dispositif est le fruit d’un partenariat fructueux entre ELSAN et Docaposte, leader des plateformes de services e-santé. Facile à utiliser, ADEL est destiné aux patients des 120 cliniques ELSAN réparties dans toute la France, dans le cadre d’interventions chirurgicales programmées.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

AI in healthcare - not so fast? Study outlines challenges, dangers for machine learning

AI in healthcare - not so fast? Study outlines challenges, dangers for machine learning | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Despite being touted as next-generation cure-alls that will transform healthcare in unfathomable ways, artificial intelligence and machine learning still pose many concerns with regards to safety and responsible implementation.

BMJ Quality and Safety has published a new study that identifies short-, medium- and long-term issues that machine learning will encounter in the healthcare space – hurdles that could prevent its successful implementation in a wide are of use cases.

With everything at stake, from research and clinical guidance to direct control of critical patient safety equipment (although that is still in the future), these strata of concerns suggest that there are many challenges AI and machine learning applications will need to address as they become more ubiquitous in healthcare.

WHY IT MATTERS
Those applications are oftten hamstrung by the same problems almost every computing task is: the computer does exactly what is told, which can invite or exacerbate unintended consequences. BMJ surveyed various applications that are currently in use, as well as those on the near horizon and beyond.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Change Healthcare, Health Fidelity Apply AI to Risk Adjustment

Change Healthcare, Health Fidelity Apply AI to Risk Adjustment | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Change Healthcare and Health Fidelity have announced a collaboration to offer AI-driven risk adjustment coding solutions for Medicare Advantage, ACA commercial, and Medicaid payers.

The tool leverages natural language processing (NLP) and machine learning to increase the accuracy of claims and help health plans meet their compliance obligations.

By transforming the risk adjustment process from a manual task into an automated process, health plans will be able to ensure that coding is accurate and complete, the companies said.

“Risk adjustment requires a high level of clinical data acquisition and careful analysis of millions of medical records to assign the proper diagnosis code to claims,” said Doug Duskin, senior vice president and general manager, Clinical Review, Change Healthcare.

“Health Fidelity’s NLP engine has demonstrated very high sensitivity in identifying ICD and HCC codes, enabling their clients to realize a 20-30 percent increase in risk capture. This added capability is exciting as we expect it will lead to better gap closure and improved quality of care and outcomes for members.”

The two companies will offer a single enterprise solution that combines analytics, chart retrieval, coding, and submission. Artificial intelligence will help select high-risk charts for further review.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

GE Healthcare partners with Vanderbilt on AI-based immunotherapy guidance and diagnostics

GE Healthcare partners with Vanderbilt on AI-based immunotherapy guidance and diagnostics | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

GE Healthcare is teaming up with Vanderbilt University Medical Center to develop more precise cancer immunotherapy diagnostics that use artificial intelligence to predict both efficacy and potential side effects.

The five-year partnership will aim to produce multiple diagnostic tools, using anonymized demographic, genomic, tumor, cellular, proteomic and imaging data from thousands of VUMC cancer patients.

“This partnership is a great example of the increasing convergence of the tools, technologies and data used by therapy innovators and healthcare providers,” said GE Healthcare’s president and CEO, Kieran Murphy.

The two aim to make the first analytics application prototype available by the end of 2019.

“Immunotherapy offers tremendous promise but given the current unpredictability of some patients’ reactions to treatments, it is also associated with increased morbidity and cost,” added Jeff Balser, president and CEO of Vanderbilt University Medical Center and dean of the Vanderbilt University School of Medicine.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Fitbit launches bring-your-own-device program for the NIH’s All of Us megastudy

Fitbit launches bring-your-own-device program for the NIH’s All of Us megastudy | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Fitbit and the National Institutes of Health (NIH) have launched a bring-your-own-device project for participants in the All of Us research program, with its first foray into wearables and digital health technology being led by Scripps Research.

Fitbit users that are currently enrolled in the Precision Medicine Initiative program can now sync their accounts and share their data with NIH researchers, including readouts of physical activity, heart rate, sleep quality and health outcomes. The device will not be required to participate.

The All of Us program launched nationwide in May 2018 with the goal of enrolling at least one million people. It aims to support a wide range of studies by building one of the largest and most diverse datasets based on individual lifestyles, environmental factors and genetics. Participants will share different types of health information through surveys, electronic medical records, biological samples and digital health tracking.

“Collecting real-world, real-time data through digital technologies will become a fundamental part of the program,” Eric Dishman, director of the All of Us program, said in a statement.

“This information in combination with many other data types will give us an unprecedented ability to better understand the impact of lifestyle and environment on health outcomes and, ultimately, develop better strategies for keeping people healthy in a very precise, individualized way,” Dishman said.

more...
No comment yet.